P39900 (MMP12_HUMAN) Homo sapiens (Human)
Macrophage metalloelastase UniProtKBInterProSTRINGInteractive Modelling
470 aa; Sequence (Fasta)
Available Structures
86 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Productive complex between MMP-12 and synthetic triple-helical collagen, revealed through paramagne… |
Heteromer | 100 | 2×ZN; 3×CA; | |||
| Potempin A (PotA) from Tannerella forsythia in complex with the catalytic domain of human MMP-12 |
Heteromer G8UM88; | 99.37 | 3×CA; 2×ZN; | |||
| Crystal Structure of MMP-12 complexed to 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl-4-(4-ethox… | homo-6-mer | 100 | 6×HAE; 6×CP8; 12×ZN; 24×CA; | |||
| Crystal Structure of MMP-12 complexed to (2R)-3-({[4-[(pyridin-4-yl)phenyl]-thien-2-yl}carboxamido)… | homo-6-mer | 100 | 9×PF3; 6×HAE; 12×ZN; 12×CA; | |||
| Crystal structure of the catalytic domain of MMP-12 in complex with a twin inhibitor. | homo-2-mer | 99.37 | 4×ZN; 6×CA; 8×GOL; 1×0ZD; 1×PEG; | |||
| Crystal structure of the catalytic domain of MMP-12 in complex with a twin inhibitor. | homo-2-mer | 99.37 | 4×ZN; 6×CA; 2×PGO; 1×DMS; 2×PEG; 1×L29; 1×GOL; | |||
| Crystal structure of full-length human MMP-12 | monomer | 99.73 | 2×ZN; 4×CA; 1×HAE; | |||
| Solution structure of the hemopexin-like domain of MMP12 | monomer | 100 | 1×CA; | |||
| Crystal Structure Analysis of human Macrophage Elastase MMP-12 | monomer | 100 | 2×ZN; 3×CA; 1×CGS; | |||
| NMR Solution Structure of the Inhibitor-Free State of Macrophage Metalloelastase (MMP-12) | monomer | 99.39 | 2×ZN; 3×CA; | |||
| Membrane Bilayer complex with Matrix Metalloproteinase-12 at its Beta-face | monomer | 99.39 | 2×ZN; 3×CA; 125×PX4; | |||
| Solution structure of the wild-type catalytic domain of human matrix metalloproteinase 12 (MMP-12) … | monomer | 100 | 2×ZN; 1×DSV; | |||
| Membrane Bilayer complex with Matrix Metalloproteinase-12 at its Alpha-face | monomer | 99.39 | 2×ZN; 3×CA; 125×PX4; | |||
| Binary enzyme-product complexes of human MMP12 | monomer | 99.39 | 2×ZN; 3×CA; | |||
| MMP12 complex with a beta hydroxy carboxylic acid | monomer | 100 | 2×ZN; 1×CA; 1×077; 2×SO4; | |||
| Ternary enzyme-product-inhibitor complexes of human MMP12 | monomer | 99.39 | 2×ZN; 3×CA; 1×HAE; | |||
| MMP12 complex with a beta hydroxy carboxylic acid | monomer | 100 | 2×ZN; 1×CA; 1×068; 3×SO4; | |||
| MMP12 complex with a beta hydroxy carboxylic acid | monomer | 100 | 4×SO4; 2×ZN; 1×CA; 1×576; | |||
| Crystal structure of MMP-12 complexed to 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl-4-(4-ethox… | monomer | 100 | 2×ZN; 3×CA; 1×DEO; | |||
| Crystal structure of the catalytic domain of human MMP12 complexed with acetohydroxamic acid at ato… | monomer | 99.37 | 2×ZN; 3×CA; 1×HAE; | |||
| Crystal structure of human MMP-12 (Macrophage Elastase) at true atomic resolution | monomer | 99.37 | 2×ZN; 3×CA; 1×BAT; | |||
| Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-(2-nitroso-… | monomer | 99.37 | 2×ZN; 3×CA; 1×HS4; | |||
| Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor 4-fluoro-N-(2… | monomer | 99.37 | 2×ZN; 3×CA; 1×HS6; | |||
| Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor 4-fluoro-N-(2… | monomer | 99.37 | 2×ZN; 3×CA; 1×HS5; | |||
| Crystal structure of the catalytic domain of Human MMP12 in complex with selective phosphinic inhib… | monomer | 99.37 | 2×ZN; 3×CA; 1×R47; | |||
| Human MMP-12 complexed with the peptide IAG | monomer | 99.37 | 2×ZN; 3×CA; | |||
| Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor (R)-N-(3-hydr… | monomer | 99.37 | 2×ZN; 3×CA; 1×HS3; | |||
| Crystal structure of a mutated catalytic domain of Human MMP12 in complex with an hydroxamate analo… | monomer | 99.37 | 2×ZN; 3×CA; 1×56O; | |||
| Crystal structure of MMP12 in complex with inhibitor BE7. | monomer | 99.37 | 2×ZN; 3×CA; 1×B9N; 1×EDO; | |||
| Uninhibited form of human MMP-12 | monomer | 99.37 | 2×ZN; 3×CA; | |||
| Crystal structure of a dimeric based inhibitor JG34 in complex with the MMP-12 catalytic domain | monomer | 99.37 | 2×ZN; 3×CA; 1×2IF; 1×EDO; 1×PGR; | |||
| Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-(2-nitroso-… | monomer | 99.37 | 2×ZN; 3×CA; 1×HS7; | |||
| MMP12 in a complex with the dimeric adduct: 5-(5-phenylhydantoin)-5-phenylhydantoin | monomer | 99.37 | 3×ZN; 4×CA; 3×IMD; 3×CL; 1×0D2; 1×EDO; | |||
| Crystal structure of MMP12 in complex with carboxylic inhibitor LP165. | monomer | 99.37 | 2×ZN; 3×CA; 1×BKW; | |||
| Crystal structure of the catalytic domain of Human MMP12 in complex with a carboxylate inhibitor re… | monomer | 98.73 | 2×ZN; 3×CA; 1×55L; | |||
| Crystal structure of a mutated catalytic domain of Human MMP12 in complex with RXP470 | monomer | 98.73 | 2×ZN; 3×CA; 1×R47; | |||
| Human MMP12 in complex with non-zinc chelating inhibitor | monomer | 99.37 | 2×ZN; 3×CA; 1×HAE; 1×EEF; 2×P6G; | |||
| Crystal structure of a double mutant catalytic domain of Human MMP12 in complex with an hydroxamate… | monomer | 98.73 | 2×ZN; 3×CA; 1×56O; | |||
| Crystal structure of human MMP-12 in complex with acetohydroxamic acid and a bicyclic inhibitor | monomer | 99.37 | 2×ZN; 3×CA; 1×37A; 1×HAE; | |||
| Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor NNGH at 1.3 A… | monomer | 99.37 | 2×ZN; 3×CA; 1×NGH; | |||
| Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor NNGH | monomer | 99.37 | 2×ZN; 3×CA; 1×NGH; | |||
| Crystal structure of the catalytic domain of Human MMP12 in complex with selective phosphinic inhib… | monomer | 99.37 | 2×ZN; 3×CA; 1×R45; | |||
| Crystal structure of the catalytic domain of Human MMP12 in complex with selective phosphinic inhib… | monomer | 99.37 | 2×ZN; 3×CA; 1×R4B; | |||
| Crystal structure of the catalytic domain of Human MMP12 in complex with a broad spectrum hydroxama… | monomer | 99.37 | 2×ZN; 3×CA; 1×10B; 3×PGO; 3×PEG; 1×GOL; | |||
| Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-hydroxy-2-(… | monomer | 99.37 | 2×ZN; 3×CA; 1×JT5; | |||
| Human MMP12 in complex with L-glutamate motif inhibitor | monomer | 99.37 | 2×ZN; 3×CA; 1×EEG; 1×IMD; 1×GOL; | |||
| Crystal structure of the catalytic domain of Human MMP12 in complex with a selective carboxylate ba… | monomer | 99.37 | 2×ZN; 3×CA; 1×Y38; 4×PGO; 1×PGR; 4×GOL; 3×PEG; | |||
| Human MMP12 in complex with L-glutamate motif inhibitor | monomer | 99.37 | 2×ZN; 3×CA; 1×E37; 1×GOL; 2×EDO; 1×PGR; 3×PGO; 1×IMD; | |||
| Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor (S)-N-(2,3-di… | monomer | 99.37 | 2×ZN; 3×CA; 1×HS1; | |||
| Human MMP12 in complex with a PEG-linked bifunctional L-glutamate motif inhibitor | monomer | 98.73 | 2×ZN; 3×CA; 1×L88; 3×GOL; 2×PGO; 2×DMS; 4×EDO; 1×PEG; | |||
| Human MMP12 in complex with non-zinc chelating inhibitor | monomer | 99.37 | 2×ZN; 3×CA; 1×EEG; 1×HAE; 3×P6G; | |||
| Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-Hydroxy-2-(… | monomer | 99.37 | 2×ZN; 3×CA; 1×NHK; | |||
| Catalytic domain of human MMP-12 complexed with hydroxamic acid and paramethoxy-sulfonyl amide | monomer | 99.37 | 2×ZN; 3×CA; 1×HAE; 1×M4S; | |||
| Crystal structure of MMP12 mutant K421A in complex with RXP470.1 conjugated with fluorophore Cy5,5 … | monomer | 98.73 | 2×ZN; 3×CA; 1×BR; 2×EDO; 1×R47; 1×6PJ; | |||
| Human MMP12 in complex with 3-(5-(1,2-dithiolan-3-yl)pentanamido)propane-1-sulfonate | monomer | 99.37 | 2×ZN; 3×CA; 1×HAE; 1×8NT; | |||
| Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor paramethoxy-s… | monomer | 99.37 | 2×ZN; 3×CA; 1×Z79; | |||
| Human MMP12 in complex with non-zinc chelating inhibitor | monomer | 99.37 | 2×ZN; 3×CA; 1×EEA; 1×HAE; | |||
| Human MMP-12 catalytic domain in complex with*N*-Hydroxy-2-(2-phenylethylsulfonamido)acetamide | monomer | 99.37 | 2×ZN; 3×CA; 1×KLG; | |||
| Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-hydroxy-2-(… | monomer | 99.37 | 2×ZN; 3×CA; 1×D3X; | |||
| Human MMP-12 catalytic domain in complex with*(R)-N*-Hydroxy-1-(phenethylsulfonyl)pyrrolidine-2-car… | monomer | 99.37 | 2×ZN; 3×CA; 1×KLH; | |||
| Unraveling hidden allosteric regulatory sites in structurally homologues metalloproteases | monomer | 99.37 | 2×ZN; 3×CA; | |||
| Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor (R)-2-(4-meth… | monomer | 99.37 | 2×ZN; 3×CA; 1×TBL; | |||
| Human MMP12 catalytic domain in complex with AP280 | monomer | 99.37 | 2×ZN; 3×CA; 1×K0Q; 1×HAE; | |||
| Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor (R)-2-(biphen… | monomer | 99.37 | 2×ZN; 3×CA; 1×BDL; | |||
| Human MMP12 in complex with non-zinc chelating inhibitor | monomer | 99.37 | 2×ZN; 3×CA; 1×EEC; 1×GLY; | |||
| Human MMP-12 in complex with two peptides PQG and IAG | monomer | 99.37 | 2×ZN; 3×CA; | |||
| Discovery of the first orally bioavailable ADAMTS7 inhibitor BAY-9835 | monomer | 99.37 | 2×ZN; 3×CA; 1×A1H07; 1×PEG; 1×CL; | |||
| Human MMP12 in complex with L-glutamate motif inhibitor | monomer | 99.37 | 2×ZN; 3×CA; 1×QEG; | |||
| Human MMP12 catalytic domain in complex with*N*-Hydroxy-2-(2-(4-methoxyphenyl)ethylsulfonamido)acet… | monomer | 99.37 | 2×ZN; 3×CA; 1×KLJ; | |||
| Does a Fast Nuclear Magnetic Resonance Spectroscopy- and X-Ray Crystallography Hybrid Approach Prov… | monomer | 99.37 | 3×ZN; 3×CA; 3×ACT; 1×CGS; | |||
| Crystal structure of MMP12 in complex with RXP470.1 conjugated with fluorophore Cy5,5 in space grou… | monomer | 99.37 | 2×ZN; 3×CA; 1×R47; 1×6PJ; 4×EDO; 1×GOL; | |||
| Human MMP12 (catalytic domain) in complex with AP316 | monomer | 99.37 | 2×ZN; 3×CA; 1×HAE; 1×K8T; | |||
| Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated ar… | monomer | 99.37 | 1×H27; 2×ZN; 3×CA; 1×PGO; 1×EDO; 1×PEG; | |||
| Solution structure of human macrophage elastase (MMP-12) catalytic domain complexed with a gamma-ke… | monomer | 100 | 2×ZN; 3×CA; 1×HSI; | |||
| Solution Structure of MMP12 in the presence of N-isobutyl-N-4-methoxyphenylsulfonyl]glycyl hydroxam… | monomer | 99.37 | 2×ZN; 3×CA; 1×NGH; | |||
| Solution Structure of matrix metalloproteinase 12 (MMP12) in the presence of N-Isobutyl-N-[4-methox… | monomer | 99.37 | 2×ZN; 3×CA; 1×NGH; | |||
| Crystal structure of MMP12 in complex with inhibitor BE4. | monomer | 98.73 | 2×ZN; 3×CA; 1×B9Z; 1×DIO; | |||
| Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated tr… | monomer | 98.73 | 2×ZN; 3×CA; 1×67M; 10×EDO; | |||
| Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated th… | monomer | 98.73 | 1×67F; 2×ZN; 3×CA; 1×DMS; 1×PGO; | |||
| Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated tr… | monomer | 98.73 | 1×V24; 2×ZN; 3×CA; 1×PGO; | |||
| Human catalytic MMP-12 in complex with 5-(1,2-dithiolan-3-yl)-N-(3-hydroxypropyl)pentanamide | monomer | 99.36 | 2×ZN; 3×CA; 1×HAE; 1×8NW; | |||
| Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated tr… | monomer | 98.72 | 1×V28; 2×ZN; 3×CA; | |||
| Crystal structure of the catalytic domain of Human MMP12 in complex with selective phosphinic inhib… | monomer | 99.34 | 2×ZN; 3×CA; 1×R4C; 1×IMD; | |||
| Crystal structure of MMP12 in complex with hydroxamate inhibitor LP168. | monomer | 99.34 | 1×LPW; 2×ZN; 3×CA; | |||
| High-Resolution Solid-State NMR Structure of a 17.6 kDa Protein | monomer | 99.34 | 1×CO; | |||
| Paramagnetic shifts in solid-state NMR of Proteins to elicit structural information | monomer | 99.34 | 1×CO; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3ba0.1.A | monomer | 0.78 | 2×ZN; 4×CA; 1×HAE; | 99.73 | ||
| 1su3.2.A | monomer | 0.72 | 3×CA; 1×ZN; | 49.89 | ||